Drugs / ReJoinTM
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02855073 | Jul 2014 → Dec 2019 | articular cartilage disorder, osteoarthritis, knee | Shanghai AbelZeta Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ReJoinTM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02855073 ↗ |
| Route | Other | “intra-articular injection of HA and haMPCs” PMID 32043426 ↗ Feb 2020 |